Therapeutic treatment of New Zealand mouse disease by a limited number of anti-idiotypic antibodies conjugated with neocarzinostatin

J Clin Invest. 1990 Sep;86(3):769-76. doi: 10.1172/JCI114773.

Abstract

-81 and NE-1 idiotypes (Id) of human nephritogenic anti-DNA antibodies are interspecies Id expressed also in NZB/W F1 mice. We tried to manipulate the synthesis of spontaneously occurring anti-DNA antibody using monoclonal anti-Id antibodies (D1E2 and 1F5) conjugated with a cytotoxic agent, neocarzinostatin (NCS). In vivo administration of anti-Id antibodies conjugated with NCS brought about an improvement in the survival rate of female NZB/W F1 mice. It also caused a retardation of development of lupus nephritis and decreased the numbers of anti-DNA-producing cells. The suppression of anti-DNA antibody synthesis was specific and Id-mediated. The results indicate that the use of a limited number of anti-Id antibodies in combination with a cytotoxic agent may be applicable therapeutically to autoimmune diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / therapeutic use*
  • Antibodies, Anti-Idiotypic / therapeutic use*
  • Antibodies, Antinuclear / immunology*
  • Autoimmune Diseases / therapy*
  • DNA, Single-Stranded / immunology
  • Immunotherapy
  • Immunotoxins / therapeutic use*
  • Kidney Diseases / pathology
  • Kidney Diseases / therapy
  • Kidney Glomerulus / immunology
  • Kidney Glomerulus / pathology
  • Mice
  • Mice, Inbred NZB
  • Proteinuria / therapy
  • Spleen / immunology
  • Zinostatin / therapeutic use*

Substances

  • Antibiotics, Antineoplastic
  • Antibodies, Anti-Idiotypic
  • Antibodies, Antinuclear
  • DNA, Single-Stranded
  • Immunotoxins
  • Zinostatin